Search Results - "McMenamin, Una"

Refine Results
  1. 1

    Statin use and risk of liver cancer: Evidence from two population‐based studies by Tran, Kim Tu, McMenamin, Úna C., Coleman, Helen G., Cardwell, Chris R., Murchie, Peter, Iversen, Lisa, Lee, Amanda J., Thrift, Aaron P.

    Published in International journal of cancer (01-03-2020)
    “…Epidemiological studies of statin use and liver cancer risk have produced conflicting results. We examined the association between statin use and risk of…”
    Get full text
    Journal Article
  2. 2

    Circulating Sex Hormones Are Associated With Gastric and Colorectal Cancers but Not Esophageal Adenocarcinoma in the UK Biobank by McMenamin, Úna C., Liu, Peipei, Kunzmann, Andrew T., Cook, Michael B., Coleman, Helen G., Johnston, Brian T., Cantwell, Marie M., Cardwell, Chris R.

    Published in The American journal of gastroenterology (01-03-2021)
    “…Gastrointestinal cancers show an unexplained male predominance, but few prospective studies have investigated sex hormones and gastrointestinal cancer risk…”
    Get full text
    Journal Article
  3. 3

    PTGS2 (Cyclooxygenase-2) Expression and Survival among Colorectal Cancer Patients: A Systematic Review by KUNZMANN, Andrew T, MURRAY, Liam J, CARDWELL, Chris R, MCSHANE, Charlene M, MCMENAMIN, Una C, CANTWELL, Marie M

    “…Studies have examined whether tumor expression of PTGS2 (also known as COX-2), an enzyme inhibited by nonsteroidal anti-inflammatory drugs such as aspirin, is…”
    Get full text
    Journal Article
  4. 4

    Use of proton pump inhibitors and histamine-2 receptor antagonists and risk of gastric cancer in two population-based studies by Liu, Peipei, McMenamin, Úna C., Johnston, Brian T., Murchie, Peter, Iversen, Lisa, Lee, Amanda J., Vissers, Pauline A. J., Cardwell, Chris R.

    Published in British journal of cancer (21-07-2020)
    “…Background Studies have shown increased gastric cancer risk in users of proton pump inhibitors (PPI) and histamine-2 receptor antagonists, questioning the…”
    Get full text
    Journal Article
  5. 5

    The Risk of Cardiovascular Disease in Prostate Cancer Patients Receiving Androgen Deprivation Therapies by Cardwell, Chris R., O’Sullivan, Joe M., Jain, Suneil, Harbinson, Mark T., Cook, Michael B., Hicks, Blánaid M., McMenamin, Úna C.

    Published in Epidemiology (Cambridge, Mass.) (01-05-2020)
    “…BACKGROUND:Androgen deprivation therapy (ADT), with a proven role in prostate cancer management, has been associated with various cardiovascular diseases…”
    Get full text
    Journal Article
  6. 6

    Non-pharmacological interventions for cognitive impairment due to systemic cancer treatment by Treanor, Charlene J, McMenamin, Una C, O'Neill, Roisin F, Cardwell, Chris R, Clarke, Mike J, Cantwell, Marie, Donnelly, Michael

    Published in Cochrane database of systematic reviews (16-08-2016)
    “…It is estimated that up to 75% of cancer survivors may experience cognitive impairment as a result of cancer treatment and given the increasing size of the…”
    Get more information
    Journal Article
  7. 7
  8. 8

    Hormone therapy use and the risk of acute kidney injury in patients with prostate cancer: a population-based cohort study by Cardwell, Chris R., O’Sullivan, Joe M., Jain, Suneil, Hicks, Blánaid M., Devine, Paul A., McMenamin, Úna C.

    Published in Prostate cancer and prostatic diseases (01-12-2021)
    “…Background Hormone therapy is widely used in prostate cancer. However, studies have raised concerns that hormone therapy, particularly the use of…”
    Get full text
    Journal Article
  9. 9

    Blood biomarkers for early diagnosis of oesophageal cancer: a systematic review by Kunzmann, Andrew T, McMenamin, Úna C, Spence, Andrew D, Gray, Ronan T, Murray, Liam J, Turkington, Richard C, Coleman, Helen G

    “…BACKGROUNDOesophageal cancer prognosis remains poor owing to the inability to detect the disease at an early stage. Nontissue (serum, urinary or salivary)…”
    Get full text
    Journal Article
  10. 10

    Physical activity, sedentary behaviour and risk of oesophago-gastric cancer: A prospective cohort study within UK Biobank by Kunzmann, Andrew T, Mallon, Kristian P, Hunter, Ruth F, Cardwell, Chris R, McMenamin, Úna C, Spence, Andrew D, Coleman, Helen G

    Published in United European gastroenterology journal (01-10-2018)
    “…Background Few observational studies have assessed the role of physical activity in oesophago-gastric cancer risk. Objective This prospective cohort study…”
    Get full text
    Journal Article
  11. 11

    Concurrent and future risk of endometrial cancer in women with endometrial hyperplasia: A systematic review and meta-analysis by Doherty, Michelle T, Sanni, Omolara B, Coleman, Helen G, Cardwell, Chris R, McCluggage, W Glenn, Quinn, Declan, Wylie, James, McMenamin, Úna C

    Published in PloS one (28-04-2020)
    “…To inform treatment decisions in women diagnosed with endometrial hyperplasia, quantification of the potential for concurrent endometrial cancer and the future…”
    Get full text
    Journal Article
  12. 12

    Coffee consumption by type and risk of digestive cancer: a large prospective cohort study by Tran, Kim Tu, Coleman, Helen G., McMenamin, Úna C., Cardwell, Chris R.

    Published in British journal of cancer (01-05-2019)
    “…Background Inverse associations have been observed between coffee consumption and liver cancer, but associations for other digestive cancers are unclear. Few…”
    Get full text
    Journal Article
  13. 13

    Factors associated with interobserver variation amongst pathologists in the diagnosis of endometrial hyperplasia: A systematic review by McCoy, Chloe A, Coleman, Helen G, McShane, Charlene M, McCluggage, W Glenn, Wylie, James, Quinn, Declan, McMenamin, Úna C

    Published in PloS one (29-04-2024)
    “…Reproducible diagnoses of endometrial hyperplasia (EH) remains challenging and has potential implications for patient management. This systematic review aimed…”
    Get full text
    Journal Article
  14. 14

    Survival outcomes in endometrial cancer patients according to diabetes: a systematic review and meta-analysis by McVicker, Lauren, Cardwell, Christopher R, Edge, Lauren, McCluggage, W Glenn, Quinn, Declan, Wylie, James, McMenamin, Úna C

    Published in BMC cancer (20-04-2022)
    “…Diabetes is an established risk factor for endometrial cancer development but its impact on prognosis is unclear and epidemiological studies to date have…”
    Get full text
    Journal Article
  15. 15

    Cancer-specific mortality in breast cancer patients with hypothyroidism: a UK population-based study by McVicker, Lauren, Cardwell, Christopher R., McIntosh, Stuart A., McMenamin, Úna C.

    Published in Breast cancer research and treatment (01-09-2022)
    “…Purpose Epidemiological studies have indicated a higher prevalence of hypothyroidism in breast cancer patients, possibly related to shared risk factors and…”
    Get full text
    Journal Article
  16. 16
  17. 17

    Adenocarcinoma risk in gastric atrophy and intestinal metaplasia: a systematic review by Spence, Andrew D, Cardwell, Chris R, McMenamin, Úna C, Hicks, Blanaid M, Johnston, Brian T, Murray, Liam J, Coleman, Helen G

    Published in BMC gastroenterology (11-12-2017)
    “…Gastric cancer (GC) has a poor prognosis with wide variation in survival rates across the world. Several studies have shown premalignant lesions gastric…”
    Get full text
    Journal Article
  18. 18

    Do smoking and alcohol behaviours influence GI cancer survival? by McMenamin, Úna C., McCain, Stephen, Kunzmann, Andrew T.

    “…Little is known about the role of alcohol and smoking in GI cancer survival compared to GI cancer development. We systematically reviewed the evidence for a…”
    Get full text
    Journal Article
  19. 19

    Model for Identifying Individuals at Risk for Esophageal Adenocarcinoma by Kunzmann, Andrew T., Thrift, Aaron P., Cardwell, Chris R., Lagergren, Jesper, Xie, Shaohua, Johnston, Brian T., Anderson, Lesley A., Busby, John, McMenamin, Úna C., Spence, Andrew D., Coleman, Helen G.

    Published in Clinical gastroenterology and hepatology (01-08-2018)
    “…The prognosis for most patients with esophageal adenocarcinoma (EAC) is poor because they present with advanced disease. Models developed to identify patients…”
    Get full text
    Journal Article
  20. 20

    Hormone replacement therapy in women with cancer and risk of cancer-specific mortality and cardiovascular disease: a protocol for a cohort study from Scotland and Wales by McMenamin, Úna, Hicks, Blánaid, Hughes, Carmel, Murchie, Peter, Hippisley-Cox, Julia, Ranger, Tom, Coupland, Carol, Cardwell, Chris

    Published in BMC cancer (24-03-2021)
    “…Hormone replacement therapy (HRT) is widely used and has proven benefits for women with menopausal symptoms. An increasing number of women with cancer…”
    Get full text
    Journal Article